4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-23-023749
CFO and CBO sold 3,439 shares at $7.27 ($25,002)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Henderson Molly CFO and CBO | 2023-04-06 | Sale 10b5-1 | −3,439 | $7.27 | $25,002 | 72,576 | D |
| Open-market sales · 3,439 sh · avg $7.27 · $25,002 | |||||||
Loading xslF345X04/doc4.xml…